FI972583L - Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT1D-reseptoriantagonisteina - Google Patents

Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT1D-reseptoriantagonisteina Download PDF

Info

Publication number
FI972583L
FI972583L FI972583A FI972583A FI972583L FI 972583 L FI972583 L FI 972583L FI 972583 A FI972583 A FI 972583A FI 972583 A FI972583 A FI 972583A FI 972583 L FI972583 L FI 972583L
Authority
FI
Finland
Prior art keywords
preparation
receptor antagonists
spiro compounds
5ht1d receptor
tetracyclic spiro
Prior art date
Application number
FI972583A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972583A0 (fi
FI972583A7 (fi
Inventor
Laramie Mary Gaster
Francis David King
Paul Adrian Wyman
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426029.6A external-priority patent/GB9426029D0/en
Priority claimed from GBGB9512920.1A external-priority patent/GB9512920D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI972583A0 publication Critical patent/FI972583A0/fi
Publication of FI972583L publication Critical patent/FI972583L/fi
Publication of FI972583A7 publication Critical patent/FI972583A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI972583A 1994-12-22 1995-12-06 Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja nii den käyttö 5HT1D-reseptoriantagonisteina FI972583A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426029.6A GB9426029D0 (en) 1994-12-22 1994-12-22 Novel compounds
GBGB9512920.1A GB9512920D0 (en) 1995-06-24 1995-06-24 Novel compounds
PCT/EP1995/004889 WO1996019477A1 (en) 1994-12-22 1995-12-06 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists

Publications (3)

Publication Number Publication Date
FI972583A0 FI972583A0 (fi) 1997-06-17
FI972583L true FI972583L (fi) 1997-08-19
FI972583A7 FI972583A7 (fi) 1997-08-19

Family

ID=26306239

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972583A FI972583A7 (fi) 1994-12-22 1995-12-06 Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja nii den käyttö 5HT1D-reseptoriantagonisteina

Country Status (27)

Country Link
US (1) US5972951A (de)
EP (1) EP0799226B1 (de)
JP (1) JPH10510821A (de)
CN (1) CN1175256A (de)
AP (1) AP757A (de)
AR (1) AR002011A1 (de)
AT (1) ATE199085T1 (de)
AU (1) AU697361B2 (de)
BG (1) BG61977B1 (de)
BR (1) BR9510419A (de)
CA (1) CA2208244A1 (de)
CZ (1) CZ192397A3 (de)
DE (1) DE69520075T2 (de)
DZ (1) DZ1957A1 (de)
ES (1) ES2153907T3 (de)
FI (1) FI972583A7 (de)
HU (1) HUT77650A (de)
IL (1) IL116486A0 (de)
MA (1) MA23753A1 (de)
MX (1) MX9704777A (de)
NO (1) NO972910L (de)
NZ (1) NZ298036A (de)
OA (1) OA10610A (de)
PL (1) PL321048A1 (de)
SK (1) SK80297A3 (de)
TR (1) TR199501597A2 (de)
WO (1) WO1996019477A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
GB9522845D0 (en) * 1995-11-08 1996-01-10 Smithkline Beecham Plc Novel compounds
EP0861257A1 (de) * 1995-11-08 1998-09-02 Smithkline Beecham Plc Spiro-piperdin derivate als 5ht-receptor antagonisten
EP0862565A1 (de) * 1995-11-22 1998-09-09 Smithkline Beecham Plc Tricyclische spiroverbindungen als 5ht1d-rezeptorantagonisten
GB9605883D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Novel compounds
GB9606396D0 (en) * 1996-03-27 1996-06-05 Smithkline Beecham Plc Novel compounds
US6156783A (en) * 1996-04-30 2000-12-05 Smithkline Beecham P.L.C. Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
FR2761069A1 (fr) * 1997-03-20 1998-09-25 Pf Medicament Spiroamines derivees de dihydrobenzofuranes, leur preparation et leur application comme medicaments
AU6123699A (en) * 1998-10-16 2000-05-08 Takeda Chemical Industries Ltd. Nitrogenous fused heterocycle compounds, process for the preparation thereof andagents containing the same
DE10051981A1 (de) 2000-10-20 2002-05-02 Bayer Ag Substituierte Phenyluracile
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
JP5043428B2 (ja) * 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JP5304981B2 (ja) 2005-12-26 2013-10-02 日産化学工業株式会社 １，３−ビス（置換フェニル）−３−ヒドロキシプロパン−１−オンおよび２−プロペン−１−オン化合物およびその塩
KR20100014811A (ko) 2007-04-20 2010-02-11 데시페라 파마슈티칼스, 엘엘씨. 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제
EP2520561B1 (de) 2007-06-08 2016-02-10 MannKind Corporation IRE-1a-Inhibitoren
JP5349303B2 (ja) 2007-06-27 2013-11-20 日産化学工業株式会社 ３−ヒドロキシプロパン−１−オン化合物、２−プロペン−１−オン化合物およびイソキサゾリン化合物の製造方法
CN105218565A (zh) 2008-10-17 2016-01-06 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
MX2012004373A (es) 2009-10-14 2012-06-28 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol.
CA2788440A1 (en) 2010-02-26 2011-09-01 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
US11498903B2 (en) 2017-08-17 2022-11-15 Bristol-Myers Squibb Company 2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases
IL276398B2 (en) 2018-01-31 2026-03-01 Deciphera Pharmaceuticals Llc Combination therapy for mastocytosis
KR102708177B1 (ko) 2018-01-31 2024-09-23 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양의 치료를 위한 병용 요법
EP3938363A1 (de) 2019-03-11 2022-01-19 Teva Pharmaceuticals International GmbH Festkörperformen von ripretinib
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
PT4013412T (pt) 2019-08-12 2026-03-18 Deciphera Pharmaceuticals Llc Ripretinib para o tratamento de tumores estromais gastrointestinais
LT4013412T (lt) 2019-08-12 2026-03-25 Deciphera Pharmaceuticals, Llc Ripretinibas, skirtas virškinamojo trakto stromos navikų gydymui
CN115243681B (zh) 2019-12-30 2024-08-16 德西费拉制药有限责任公司 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物
HRP20231699T1 (hr) 2019-12-30 2024-05-10 Deciphera Pharmaceuticals, Llc Formulacije inhibitora amorfne kinaze i postupci njihove primjene
US12577211B2 (en) 2020-06-29 2026-03-17 Bacainn Biotherapeutics, Ltd. Probenecid compounds for the treatment of inflammasome-mediated lung disease
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
PT533268E (pt) 1991-09-18 2002-02-28 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d

Also Published As

Publication number Publication date
ATE199085T1 (de) 2001-02-15
AR002011A1 (es) 1998-01-07
OA10610A (en) 2002-09-06
NO972910L (no) 1997-08-14
MA23753A1 (fr) 1996-07-01
AP757A (en) 1999-09-06
EP0799226A1 (de) 1997-10-08
IL116486A0 (en) 1997-08-14
MX9704777A (es) 1997-10-31
DZ1957A1 (fr) 2002-02-17
DE69520075T2 (de) 2001-08-02
TR199501597A2 (tr) 1996-07-21
DE69520075D1 (de) 2001-03-15
ES2153907T3 (es) 2001-03-16
HUT77650A (hu) 1998-07-28
NO972910D0 (no) 1997-06-20
EP0799226B1 (de) 2001-02-07
BG101715A (bg) 1998-02-27
CZ192397A3 (en) 1997-09-17
AU697361B2 (en) 1998-10-01
PL321048A1 (en) 1997-11-24
CA2208244A1 (en) 1996-06-27
SK80297A3 (en) 1998-12-02
BG61977B1 (bg) 1998-11-30
BR9510419A (pt) 1998-05-19
NZ298036A (en) 1998-11-25
CN1175256A (zh) 1998-03-04
AU4343396A (en) 1996-07-10
US5972951A (en) 1999-10-26
WO1996019477A1 (en) 1996-06-27
FI972583A0 (fi) 1997-06-17
JPH10510821A (ja) 1998-10-20
FI972583A7 (fi) 1997-08-19
AP9701006A0 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
FI972583A0 (fi) Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT1D-reseptoriantagonisteina
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
FI944729L (fi) Perhydroisoindolijohdannaiset substanssi P:n antagonisteina
FI944394A7 (fi) Kinuklidiinijohdannaisia P-aineen antagonisteina
FI960399A7 (fi) Perhydroisoindolijohdannaisia P-aineen antagonisteina
PT98929A (pt) Processo para a preparacao de antagonistas de receptores muscarinicos, nomeadamente compostos azabi- ou triciclicos
HUP0003748A3 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives, process for their preparation their use and pharmaceutical compositions containing the same
EE200100540A (et) Asendusega bitsüklilised heterotsüklid, nende valmistamismeetod ja kasutamine rasvumisvastaste ja hüpokolesteroleemsete agensitena
FI940229L (fi) Trisykliset kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
FI20002725A7 (fi) 2,5-diokso-2,5-dihydro-1Hbents[b]atsepiinit NMDA-reseptorin antagonisteina
ZA937505B (en) Imidazopyridine derivatives as 5-HT4 receptor antagonists
FI943933L (fi) Menetelmä fibrinogeenireseptoriantagonistien valmistamiseksi
HUP9800649A3 (en) Condesed n-heterocyclic compounds substituted with benzyloxy-group, process for producing them, and their use as bradiquinin-receptor-antagonists
FI950229A7 (fi) Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistami seksi ja niiden käyttö kasvaintenvastaisina aineina
BR9709982A (pt) Derivados de indolina úteis como antagonistas do receptor 5-ht-2c
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI931881A7 (fi) Merkityt fibrinogeeni-reseptori-antagonistit, niiden käyttö ja menetelmä niiden valmistamiseksi
EP0681583A1 (de) Trizyklische heterozyklische verbindungen als 5-ht4 rezeptorantagonisten.
FI922903A7 (fi) 4-asetoksipiperidiinijohdannaiset, niiden valmistusmenetelmä ja käyttö muskariinisen M3-reseptorin antagonistina
HUP9600333A3 (en) Azole derivatives as adhesive receptor antagonists, pharmaceutical compositions containing the same and process for their preparation
ITTO910353A0 (it) Nuovi composti triciclici, procedimento per la loro preparazione
EE200000024A (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
FI971528A7 (fi) Pyrrolyylitetrahydrobentsokinoksaliinidionit, niiden valmistus ja käyt tö glutamaattireseptoriantagonisteina
FI943376L (fi) Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina